Digimed Updates
  • Home
  • SAHI Updates
  • News
  • Conference
    • ADA 2025
    • HFAI 2025
    • ATTD 2024
    • ADA 2024
    • ENDO 2022
    • ESH 2022
    • ADA 2022
    • AACE 2022
    • EASD-2021
    • HFSA-2021
    • ESC-2021
    • ADA 2021
    • ACC-2021
    • ESH-ISH-2021
    • ADA 2020
    • RSSDI 2020
    • ACC-2020
    • IDF-2019
    • EASD-2019
    • ESH-2019
    • ADA-2019
    • RSSDI-2018
    • EASD-2018
  • Specialties
    • Cardiology
    • Endocrinology
    • Conference Update
    • Other Specialties Conference
  • Subscribe
  • Contact
Select Page
Declining Clinical Benefit of ICD in Heart Failure Patients: Temporal Trend of Mortality Outcomes from Randomized Controlled Trials

Declining Clinical Benefit of ICD in Heart Failure Patients: Temporal Trend of Mortality Outcomes from Randomized Controlled Trials

The risk of sudden cardiac death in patients with heart failure has declined over time thanks to the sequential introduction of new treatments.

High Risk of Sustained Ventricular Arrhythmia Recurrence after Acute Myocarditis

High Risk of Sustained Ventricular Arrhythmia Recurrence after Acute Myocarditis

Acute myocarditis is correlated with cardiac arrhythmia in 25% of cases; ventricular tachycardia (VT) or ventricular fibrillation (VF) constitute a third of these arrhythmias.

A Variant near DHCR24 Associates with Microstructural Properties of White Matter and Peripheral Lipid Metabolism in Adolescents

A Variant near DHCR24 Associates with Microstructural Properties of White Matter and Peripheral Lipid Metabolism in Adolescents

Visceral adiposity has been associated with altered microstructural properties of white matter in adolescents.

Advances in Transcatheter Mitral and Tricuspid Therapies

Advances in Transcatheter Mitral and Tricuspid Therapies

Mitral stenosis is less frequent than mitral regurgitation (MR) in developed countries. MR was reported to be present in > 1% of Western type population after 70 years old and associated with an increased mortality.

Type-I Interferons in Atherosclerosis

Type-I Interferons in Atherosclerosis

Cardiovascular diseases (CVDs) are the leading cause of death worldwide

« Older Entries
Next Entries »
« Previous 1 … 84 85 86 87 88 89 Next »
  • Home
  • News
  • Conference
  • Subscribe
  • Contact
The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.
© 2021 Digimed India. All rights reserved.
  • Home
  • News
  • Conference
  • Subscribe
  • Contact
  • Facebook
  • Twitter
  • Google
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress